Correlation Between Viridian Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Lyra Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Lyra is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.88 times more return on investment than Lyra Therapeutics. However, Viridian Therapeutics is 1.14 times less risky than Lyra Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,447 in Viridian Therapeutics on November 2, 2024 and sell it today you would earn a total of 561.00 from holding Viridian Therapeutics or generate 38.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Lyra Therapeutics |
Viridian Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |